What are the major opportunities in the Neurology Clinical Trials market? What are the strategies for the Neurology Clinical Trials market?

For detailed insights on the major opportunities and strategies in the Neurology Clinical Trials market, Read More

How does the Neurology Clinical Trials market relate to the overall economy and other similar markets?

For detailed insights on Neurology Clinical Trials's relation to the overall economy and other similar markets, Read More

What are the key dynamics influencing the Neurology Clinical Trials market growth? SWOT analysis of the Neurology Clinical Trials market.

For detailed insights on the key dynamics influencing the Neurology Clinical Trials market growth and SWOT analysis of the Neurology Clinical Trials industry, Read More

Neurology Clinical Trials Market Global Report 2026 Market Report Infographic Image

Published : March 2026

Pages : 250

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00

Neurology Clinical Trials Market Report 2026

Name: Neurology Clinical Trials Market Report 2026
Brand: The Business Research Company
Price: 4490.00 USD
Availability: InStock

Global Outlook – By Phase (Phase I, Phase II, Phase III, Phase IV), By Study Design (Interventional, Observational, Expanded Access), By Indication (Epilepsy, Parkinson’s Disease (PD), Huntington’s Disease, Stroke, Traumatic Brain Injury (TBI), Amyotrophic Lateral Sclerosis (ALS), Multiple Sclerosis, Other Indications), By End-User (Hospitals, Clinics, Research Institutes, Other End- Users) - Market Size, Trends, And Global Forecast 2025-2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Purchase This Report Download Sample PDF

Item added to cart!

Neurology Clinical Trials Market Overview

• Neurology Clinical Trials market size has reached to $5.8 billion in 2025

• Expected to grow to $8.05 billion in 2030 at a compound annual growth rate (CAGR) of 6.7%

• Growth Driver: Rising Prevalence Of Neurological Disorders Fueling The Growth Of The Market Due To Increasing Aging Population

• Market Trend: Innovative Therapies Using Monoclonal Antibodies Drive Progress In Neurological Disorder Treatment

• North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Neurology Clinical Trials Market?

Neurology clinical trials refer to research studies conducted to evaluate the safety, efficacy, and outcomes of interventions such as drugs, therapies, or diagnostic tools for neurological disorders. These trials aim to advance treatment options for conditions affecting the brain, spinal cord, and nervous system.

The main phases of neurology clinical trials are Phase I, Phase II, Phase III, and Phase IV. Phase I refers to the first stage of clinical trials involving a small group of healthy volunteers or patients to assess a drug's safety, dosage range, and side effects. In neurology, Phase I trials are essential for determining the tolerability of novel treatments targeting complex brain and nerve functions. Various study designs include interventional, observational, and expanded access, and trials focus on various indications such as epilepsy, Parkinson’s disease (PD), Huntington’s disease, stroke, traumatic brain injury (TBI), amyotrophic lateral sclerosis (ALS), muscle regeneration, and others. Key end-users of these trials include hospitals, clinics, research institutes, and others.

Neurology Clinical Trials Market Global Report 2026 Market Report bar graph

What Is The Neurology Clinical Trials Market Size and Share 2026?

The neurology clinical trials market size has grown strongly in recent years. It will grow from $5.8 billion in 2025 to $6.21 billion in 2026 at a compound annual growth rate (CAGR) of 7.0%. The growth in the historic period can be attributed to growth in neurological disease prevalence, expansion of pharmaceutical research pipelines, increased investment in neurology drug development, availability of advanced imaging tools, rising participation in clinical research.

What Is The Neurology Clinical Trials Market Growth Forecast?

The neurology clinical trials market size is expected to see strong growth in the next few years. It will grow to $8.05 billion in 2030 at a compound annual growth rate (CAGR) of 6.7%. The growth in the forecast period can be attributed to increasing use of AI-driven trial analytics, rising demand for faster trial execution, expansion of patient-centric trial models, growing integration of remote monitoring technologies, increasing focus on rare neurological conditions. Major trends in the forecast period include increasing adoption of adaptive clinical trial designs, rising use of digital patient monitoring tools, growing focus on biomarker-based neurology trials, expansion of decentralized clinical trial models, enhanced emphasis on real-world evidence generation.

Book your 30 minutes free consultation with our research experts

Global Neurology Clinical Trials Market Segmentation

1) By Phase: Phase I, Phase II, Phase III, Phase IV

2) By Study Design: Interventional, Observational, Expanded Access

3) By Indication: Epilepsy, Parkinson’s Disease (PD), Huntington’s Disease, Stroke, Traumatic Brain Injury (TBI), Amyotrophic Lateral Sclerosis (ALS), Multiple Sclerosis, Other Indications

4) By End-User: Hospitals, Clinics, Research Institutes, Other End- Users

Subsegments:

1) By Phase I: Drug Safety Evaluation, Pharmacokinetics Assessment, Dosage Range Finding, Tolerability Studies

2) By Phase II: Efficacy Evaluation, Dose Response Studies, Therapeutic Effectiveness, Biomarker Identification

3) By Phase III: Large Scale Efficacy Studies, Safety Monitoring, Comparative Effectiveness, Risk Benefit Analysis

4) By Phase IV: Post Marketing Surveillance, Long Term Safety Follow Up, Real World Evidence Collection, Quality Of Life Assessment

What Is The Driver Of The Neurology Clinical Trials Market?

The increasing prevalence of neurological disorders is expected to propel the growth of the neurology clinical trials market going forward. Neurological disorders refer to conditions that affect the brain, spinal cord, or nerves, impairing the nervous system's normal function. Neurological disorders are increasing primarily due to the aging population, as older adults are more susceptible to age-related conditions such as Alzheimer's and Parkinson's disease. Neurology clinical trials help in neurological disorders by testing new treatments, drugs, or interventions to improve diagnosis, manage symptoms, slow disease progression, and enhance patient outcomes. For instance, in September 2024, according to the Australian Institute of Health and Welfare, an Australia-based government agency, the number of Australians living with dementia is expected to more than double, increasing from 411,100 in 2023 to 849,300 by 2058. Additionally, by 2058, an estimated 315,500 men and 533,800 women will be living with dementia. Therefore, the increasing prevalence of neurological disorders is driving the growth of the neurology clinical trials industry.

Key Players In The Global Neurology Clinical Trials Market

Major companies operating in the neurology clinical trials market are AbbVie Inc., Sanofi S.A., Novartis AG, Eli Lilly and Company, Teva Pharmaceutical Industries Ltd., IQVIA Holdings Inc., Biogen Inc., ICON plc., Syneos Health, Charles River Laboratories International Inc., Parexel International Corporation, CMIC Holdings Co. Ltd., Medpace Holdings Inc., PSI CRO AG., Supernus Pharmaceuticals Inc., Worldwide Clinical Trials LLC., Ergomed plc., Biotrial S.A.S., Clinilabs Drug Development Corporation, Lindus Health Ltd.

Global Neurology Clinical Trials Market Trends and Insights

Major companies operating in the neurology clinical trials market, focusing on developing innovative solutions such as monoclonal antibodies to target specific neurological pathways, improve treatment efficacy, and accelerate the development of novel therapies. Monoclonal antibody refers to a laboratory-produced molecule engineered to recognize and bind to specific proteins or antigens, often used to target disease mechanisms with high precision in treatments and diagnostics. For instance, in July 2024, Eli Lilly and Company, a U.S.-based pharmaceutical company, launched Kisunla (donanemab-azbt) for the treatment of early symptomatic Alzheimer's disease. That slows cognitive and functional decline, allowing eligible patients more time to remain independent and participate in daily life. It targets and reduces brain amyloid plaques, with clinical trials showing up to a 35% slowing of disease progression versus placebo in those with less advanced disease.

Need data on a specific region in this market?

Request Regional Data

What Are Latest Mergers And Acquisitions In The Neurology Clinical Trials Market?

In March 2025, CLARIO, a US-based healthcare company, acquired NeuroRx for an undisclosed amount. With this acquisition, CLARIO aims to reinforce its leadership in imaging, expand its capabilities in neuroscience, and better support the development of life-changing drugs for neurological diseases. NeuroRx is a Canada-based clinical-stage pharmaceutical company involved in neurology clinical trials.

Regional Outlook

North America was the largest region in the neurology clinical trials market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Neurology Clinical Trials Market?

The neurology clinical trials market consists of revenues earned by entities by providing services such as collecting and analyzing health data, monitoring patient safety, managing trial sites, regulatory consulting, and trial design and planning. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Neurology Clinical Trials Market Report 2026?

The neurology clinical trials market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the neurology clinical trials industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abdul Wasay

Neurology Clinical Trials Market Report Forecast Analysis

Report Attribute	Details
Market Size Value In 2026	$6.21 billion
Revenue Forecast In 2035	$8.05 billion
Growth Rate	CAGR of 7.0% from 2026 to 2035
Base Year For Estimation	2025
Actual Estimates/Historical Data	2020-2025
Forecast Period	2026 - 2030 - 2035
Market Representation	Revenue in USD Billion and CAGR from 2026 to 2035
Segments Covered	Phase, Study Design, Indication, End-User
Regional Scope	Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope	The countries covered in the report are Australia, Brazil, China, France, Germany, India, ...
Key Companies Profiled	AbbVie Inc., Sanofi S.A., Novartis AG, Eli Lilly and Company, Teva Pharmaceutical Industries Ltd., IQVIA Holdings Inc., Biogen Inc., ICON plc., Syneos Health, Charles River Laboratories International Inc., Parexel International Corporation, CMIC Holdings Co. Ltd., Medpace Holdings Inc., PSI CRO AG., Supernus Pharmaceuticals Inc., Worldwide Clinical Trials LLC., Ergomed plc., Biotrial S.A.S., Clinilabs Drug Development Corporation, Lindus Health Ltd.
Customization Scope	Request for Customization
Pricing And Purchase Options	Explore Purchase Options

1. Executive Summary

1.1. Key Market Insights (2020-2035)

1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots

1.3. Major Factors Driving the Market

1.4. Top Three Trends Shaping the Market

2. Neurology Clinical Trials Market Characteristics

2.1. Market Definition & Scope

2.2. Market Segmentations

2.3. Overview of Key Products and Services

2.4. Global Neurology Clinical Trials Market Attractiveness Scoring And Analysis

2.4.1. Overview of Market Attractiveness Framework

2.4.2. Quantitative Scoring Methodology

2.4.3. Factor-Wise Evaluation

Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation

2.4.4. Market Attractiveness Scoring and Interpretation

2.4.5. Strategic Implications and Recommendations

3. Neurology Clinical Trials Market Supply Chain Analysis

3.1. Overview of the Supply Chain and Ecosystem

3.2. List Of Key Raw Materials, Resources & Suppliers

3.3. List Of Major Distributors and Channel Partners

3.4. List Of Major End Users

4. Global Neurology Clinical Trials Market Trends And Strategies

4.1. Key Technologies & Future Trends

4.1.1 Biotechnology, Genomics & Precision Medicine

4.1.2 Artificial Intelligence & Autonomous Intelligence

4.1.3 Digitalization, Cloud, Big Data & Cybersecurity

4.1.4 Industry 4.0 & Intelligent Manufacturing

4.1.5 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems

4.2. Major Trends

4.2.1 Increasing Adoption Of Adaptive Clinical Trial Designs

4.2.2 Rising Use Of Digital Patient Monitoring Tools

4.2.3 Growing Focus On Biomarker-Based Neurology Trials

4.2.4 Expansion Of Decentralized Clinical Trial Models

4.2.5 Enhanced Emphasis On Real-World Evidence Generation

5. Neurology Clinical Trials Market Analysis Of End Use Industries

5.1 Hospitals

5.2 Neurology Clinics

5.3 Research Institutes

5.4 Contract Research Organizations

5.5 Academic Medical Centers

6. Neurology Clinical Trials Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Neurology Clinical Trials Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

7.1. Global Neurology Clinical Trials PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

7.2. Global Neurology Clinical Trials Market Size, Comparisons And Growth Rate Analysis

7.3. Global Neurology Clinical Trials Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)

7.4. Global Neurology Clinical Trials Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Neurology Clinical Trials Total Addressable Market (TAM) Analysis for the Market

8.1. Definition and Scope of Total Addressable Market (TAM)

8.2. Methodology and Assumptions

8.3. Global Total Addressable Market (TAM) Estimation

8.4. TAM vs. Current Market Size Analysis

8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Neurology Clinical Trials Market Segmentation

9.1. Global Neurology Clinical Trials Market, Segmentation By Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Phase I, Phase II, Phase III, Phase IV

9.2. Global Neurology Clinical Trials Market, Segmentation By Study Design, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Interventional, Observational, Expanded Access

9.3. Global Neurology Clinical Trials Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Epilepsy, Parkinson’s Disease (PD), Huntington’s Disease, Stroke, Traumatic Brain Injury (TBI), Amyotrophic Lateral Sclerosis (ALS), Multiple Sclerosis, Other Indications

9.4. Global Neurology Clinical Trials Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Hospitals, Clinics, Research Institutes, Other End- Users

9.5. Global Neurology Clinical Trials Market, Sub-Segmentation Of Phase I, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Drug Safety Evaluation, Pharmacokinetics Assessment, Dosage Range Finding, Tolerability Studies

9.6. Global Neurology Clinical Trials Market, Sub-Segmentation Of Phase II, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Efficacy Evaluation, Dose Response Studies, Therapeutic Effectiveness, Biomarker Identification

9.7. Global Neurology Clinical Trials Market, Sub-Segmentation Of Phase III, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Large Scale Efficacy Studies, Safety Monitoring, Comparative Effectiveness, Risk Benefit Analysis

9.8. Global Neurology Clinical Trials Market, Sub-Segmentation Of Phase IV, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Post Marketing Surveillance, Long Term Safety Follow Up, Real World Evidence Collection, Quality Of Life Assessment

10. Neurology Clinical Trials Market Regional And Country Analysis

10.1. Global Neurology Clinical Trials Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

10.2. Global Neurology Clinical Trials Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Neurology Clinical Trials Market

11.1. Asia-Pacific Neurology Clinical Trials Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

11.2. Asia-Pacific Neurology Clinical Trials Market, Segmentation By Phase, Segmentation By Study Design, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Neurology Clinical Trials Market

12.1. China Neurology Clinical Trials Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

12.2. China Neurology Clinical Trials Market, Segmentation By Phase, Segmentation By Study Design, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Neurology Clinical Trials Market

13.1. India Neurology Clinical Trials Market, Segmentation By Phase, Segmentation By Study Design, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Neurology Clinical Trials Market

14.1. Japan Neurology Clinical Trials Market Overview

14.2. Japan Neurology Clinical Trials Market, Segmentation By Phase, Segmentation By Study Design, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Neurology Clinical Trials Market

15.1. Australia Neurology Clinical Trials Market, Segmentation By Phase, Segmentation By Study Design, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Neurology Clinical Trials Market

16.1. Indonesia Neurology Clinical Trials Market, Segmentation By Phase, Segmentation By Study Design, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Neurology Clinical Trials Market

17.1. South Korea Neurology Clinical Trials Market Overview

17.2. South Korea Neurology Clinical Trials Market, Segmentation By Phase, Segmentation By Study Design, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Neurology Clinical Trials Market

18.1. Taiwan Neurology Clinical Trials Market Overview

18.2. Taiwan Neurology Clinical Trials Market, Segmentation By Phase, Segmentation By Study Design, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Neurology Clinical Trials Market

19.1. South East Asia Neurology Clinical Trials Market Overview

19.2. South East Asia Neurology Clinical Trials Market, Segmentation By Phase, Segmentation By Study Design, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Neurology Clinical Trials Market

20.1. Western Europe Neurology Clinical Trials Market Overview

20.2. Western Europe Neurology Clinical Trials Market, Segmentation By Phase, Segmentation By Study Design, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Neurology Clinical Trials Market

21.1. UK Neurology Clinical Trials Market, Segmentation By Phase, Segmentation By Study Design, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Neurology Clinical Trials Market

22.1. Germany Neurology Clinical Trials Market, Segmentation By Phase, Segmentation By Study Design, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Neurology Clinical Trials Market

23.1. France Neurology Clinical Trials Market, Segmentation By Phase, Segmentation By Study Design, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Neurology Clinical Trials Market

24.1. Italy Neurology Clinical Trials Market, Segmentation By Phase, Segmentation By Study Design, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Neurology Clinical Trials Market

25.1. Spain Neurology Clinical Trials Market, Segmentation By Phase, Segmentation By Study Design, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Neurology Clinical Trials Market

26.1. Eastern Europe Neurology Clinical Trials Market Overview

26.2. Eastern Europe Neurology Clinical Trials Market, Segmentation By Phase, Segmentation By Study Design, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Neurology Clinical Trials Market

27.1. Russia Neurology Clinical Trials Market, Segmentation By Phase, Segmentation By Study Design, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Neurology Clinical Trials Market

28.1. North America Neurology Clinical Trials Market Overview

28.2. North America Neurology Clinical Trials Market, Segmentation By Phase, Segmentation By Study Design, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Neurology Clinical Trials Market

29.1. USA Neurology Clinical Trials Market Overview

29.2. USA Neurology Clinical Trials Market, Segmentation By Phase, Segmentation By Study Design, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Neurology Clinical Trials Market

30.1. Canada Neurology Clinical Trials Market Overview

30.2. Canada Neurology Clinical Trials Market, Segmentation By Phase, Segmentation By Study Design, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Neurology Clinical Trials Market

31.1. South America Neurology Clinical Trials Market Overview

31.2. South America Neurology Clinical Trials Market, Segmentation By Phase, Segmentation By Study Design, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Neurology Clinical Trials Market

32.1. Brazil Neurology Clinical Trials Market, Segmentation By Phase, Segmentation By Study Design, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Neurology Clinical Trials Market

33.1. Middle East Neurology Clinical Trials Market Overview

33.2. Middle East Neurology Clinical Trials Market, Segmentation By Phase, Segmentation By Study Design, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Neurology Clinical Trials Market

34.1. Africa Neurology Clinical Trials Market Overview

34.2. Africa Neurology Clinical Trials Market, Segmentation By Phase, Segmentation By Study Design, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Neurology Clinical Trials Market Regulatory and Investment Landscape

36. Neurology Clinical Trials Market Competitive Landscape And Company Profiles

36.1. Neurology Clinical Trials Market Competitive Landscape And Market Share 2024

36.1.1. Top 10 Companies (Ranked by revenue/share)

36.2. Neurology Clinical Trials Market - Company Scoring Matrix

36.2.1. Market Revenues

36.2.2. Product Innovation Score

36.2.3. Brand Recognition

36.3. Neurology Clinical Trials Market Company Profiles

36.3.1. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.2. Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis

36.3.3. Novartis AG Overview, Products and Services, Strategy and Financial Analysis

36.3.4. Eli Lilly and Company Overview, Products and Services, Strategy and Financial Analysis

36.3.5. Teva Pharmaceutical Industries Ltd. Overview, Products and Services, Strategy and Financial Analysis

37. Neurology Clinical Trials Market Other Major And Innovative Companies

IQVIA Holdings Inc., Biogen Inc., ICON plc, Syneos Health, Charles River Laboratories International Inc., Parexel International Corporation, CMIC Holdings Co. Ltd., Medpace Holdings Inc., PSI CRO AG, Supernus Pharmaceuticals Inc., Worldwide Clinical Trials LLC, Ergomed plc, Biotrial S.A.S., Clinilabs Drug Development Corporation, Lindus Health Ltd.

38. Global Neurology Clinical Trials Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Neurology Clinical Trials Market

40. Neurology Clinical Trials Market High Potential Countries, Segments and Strategies

40.1 Neurology Clinical Trials Market In 2030 - Countries Offering Most New Opportunities

40.2 Neurology Clinical Trials Market In 2030 - Segments Offering Most New Opportunities

40.3 Neurology Clinical Trials Market In 2030 - Growth Strategies

40.3.1 Market Trend Based Strategies

40.3.2 Competitor Strategies

41. Appendix

41.1. Abbreviations

41.2. Currencies

41.3. Historic And Forecast Inflation Rates

41.4. Research Inquiries

41.5. The Business Research Company

41.6. Copyright And Disclaimer

List Of Tables

Table 1: Global Neurology Clinical Trials Market, Overview Of Key Products - Product Examples

Table 2: Global Neurology Clinical Trials Market Attractiveness, Factor-Wise Evaluation

Table 3: Global Neurology Clinical Trials Market, Supply Chain Analysis

Table 4: Global Neurology Clinical Trials Market, Major Raw Material Providers

Table 5: Global Neurology Clinical Trials Market, Major Resource Providers

Table 6: Global Neurology Clinical Trials Market, Major Manufacturers (Suppliers)

Table 7: Global Neurology Clinical Trials Market, Major Distributors And Channel Partners

Table 8: Global Neurology Clinical Trials Market, Key Technologies & Future Trends

Table 9: Global Neurology Clinical Trials Market, Major Trends

Table 10: Global Neurology Clinical Trials Market, Major End Users

Table 11: Global Neurology Clinical Trials Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis

Table 12: Global Neurology Clinical Trials Historic Market Growth, 2020-2025, $ Billion

Table 13: Global Neurology Clinical Trials Forecast Market Growth, 2025-2030F, 2035F, $ Billion

Table 14: Global Neurology Clinical Trials Market - TAM, US$ Billion, 2025

Table 15: Global Neurology Clinical Trials Market, Segmentation By Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 16: Global Neurology Clinical Trials Market, Segmentation By Study Design, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 17: Global Neurology Clinical Trials Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 18: Global Neurology Clinical Trials Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 19: Global Neurology Clinical Trials Market, Sub-Segmentation Of Phase I, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 20: Global Neurology Clinical Trials Market, Sub-Segmentation Of Phase II, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 21: Global Neurology Clinical Trials Market, Sub-Segmentation Of Phase III, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 22: Global Neurology Clinical Trials Market, Sub-Segmentation Of Phase IV, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 23: Global Neurology Clinical Trials Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 24: Global Neurology Clinical Trials Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 25: Asia-Pacific, Neurology Clinical Trials Market, Segmentation By Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 26: Asia-Pacific, Neurology Clinical Trials Market, Segmentation By Study Design, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 27: Asia-Pacific, Neurology Clinical Trials Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 28: China, Neurology Clinical Trials Market, Segmentation By Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 29: China, Neurology Clinical Trials Market, Segmentation By Study Design, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 30: China, Neurology Clinical Trials Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 31: India, Neurology Clinical Trials Market, Segmentation By Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 32: India, Neurology Clinical Trials Market, Segmentation By Study Design, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 33: India, Neurology Clinical Trials Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 34: Japan, Neurology Clinical Trials Market, Segmentation By Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 35: Japan, Neurology Clinical Trials Market, Segmentation By Study Design, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 36: Japan, Neurology Clinical Trials Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 37: Australia, Neurology Clinical Trials Market, Segmentation By Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 38: Australia, Neurology Clinical Trials Market, Segmentation By Study Design, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 39: Australia, Neurology Clinical Trials Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 40: Indonesia, Neurology Clinical Trials Market, Segmentation By Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 41: Indonesia, Neurology Clinical Trials Market, Segmentation By Study Design, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 42: Indonesia, Neurology Clinical Trials Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 43: South Korea, Neurology Clinical Trials Market, Segmentation By Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 44: South Korea, Neurology Clinical Trials Market, Segmentation By Study Design, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 45: South Korea, Neurology Clinical Trials Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 46: Taiwan, Neurology Clinical Trials Market, Segmentation By Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 47: Taiwan, Neurology Clinical Trials Market, Segmentation By Study Design, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 48: Taiwan, Neurology Clinical Trials Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 49: South East Asia, Neurology Clinical Trials Market, Segmentation By Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 50: South East Asia, Neurology Clinical Trials Market, Segmentation By Study Design, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 51: South East Asia, Neurology Clinical Trials Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 52: Western Europe, Neurology Clinical Trials Market, Segmentation By Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 53: Western Europe, Neurology Clinical Trials Market, Segmentation By Study Design, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 54: Western Europe, Neurology Clinical Trials Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 55: UK, Neurology Clinical Trials Market, Segmentation By Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 56: UK, Neurology Clinical Trials Market, Segmentation By Study Design, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 57: UK, Neurology Clinical Trials Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 58: Germany, Neurology Clinical Trials Market, Segmentation By Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 59: Germany, Neurology Clinical Trials Market, Segmentation By Study Design, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 60: Germany, Neurology Clinical Trials Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 61: France, Neurology Clinical Trials Market, Segmentation By Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 62: France, Neurology Clinical Trials Market, Segmentation By Study Design, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 63: France, Neurology Clinical Trials Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 64: Italy, Neurology Clinical Trials Market, Segmentation By Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 65: Italy, Neurology Clinical Trials Market, Segmentation By Study Design, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 66: Italy, Neurology Clinical Trials Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 67: Spain, Neurology Clinical Trials Market, Segmentation By Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 68: Spain, Neurology Clinical Trials Market, Segmentation By Study Design, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 69: Spain, Neurology Clinical Trials Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 70: Eastern Europe, Neurology Clinical Trials Market, Segmentation By Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 71: Eastern Europe, Neurology Clinical Trials Market, Segmentation By Study Design, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 72: Eastern Europe, Neurology Clinical Trials Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 73: Russia, Neurology Clinical Trials Market, Segmentation By Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 74: Russia, Neurology Clinical Trials Market, Segmentation By Study Design, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 75: Russia, Neurology Clinical Trials Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 76: North America, Neurology Clinical Trials Market, Segmentation By Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 77: North America, Neurology Clinical Trials Market, Segmentation By Study Design, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 78: North America, Neurology Clinical Trials Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 79: USA, Neurology Clinical Trials Market, Segmentation By Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 80: USA, Neurology Clinical Trials Market, Segmentation By Study Design, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 81: USA, Neurology Clinical Trials Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 82: Canada, Neurology Clinical Trials Market, Segmentation By Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 83: Canada, Neurology Clinical Trials Market, Segmentation By Study Design, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 84: Canada, Neurology Clinical Trials Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 85: South America, Neurology Clinical Trials Market, Segmentation By Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 86: South America, Neurology Clinical Trials Market, Segmentation By Study Design, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 87: South America, Neurology Clinical Trials Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 88: Brazil, Neurology Clinical Trials Market, Segmentation By Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 89: Brazil, Neurology Clinical Trials Market, Segmentation By Study Design, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 90: Brazil, Neurology Clinical Trials Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 91: Middle East, Neurology Clinical Trials Market, Segmentation By Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 92: Middle East, Neurology Clinical Trials Market, Segmentation By Study Design, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 93: Middle East, Neurology Clinical Trials Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 94: Africa, Neurology Clinical Trials Market, Segmentation By Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 95: Africa, Neurology Clinical Trials Market, Segmentation By Study Design, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 96: Africa, Neurology Clinical Trials Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 97: Global Neurology Clinical Trials Key Competitor Estimated Market Shares, 2024, Percentage (%)

Table 98: Global Neurology Clinical Trials Market - Company Scoring Matrix

Table 99: AbbVie Inc. Financial Performance

Table 100: Sanofi S.A. Financial Performance

Table 101: Novartis AG Financial Performance

Table 102: Eli Lilly and Company Financial Performance

Table 103: Teva Pharmaceutical Industries Ltd. Financial Performance

Table 104: Global Neurology Clinical Trials Market, Competitive Benchmarking (In USD Billions)

Table 105: Global Neurology Clinical Trials Market, Competitive Dashboard

Table 106: Global Neurology Clinical Trials Market Size Gain ($ Billion), 2025 – 2030 By Country

Table 107: Global, Neurology Clinical Trials Market Size Gain ($ Billion), Segmentation By Phase, 2025 – 2030

Table 108: Global, Neurology Clinical Trials Market Size Gain ($ Billion), Segmentation By Study Design, 2025 – 2030

Table 109: Global, Neurology Clinical Trials Market Size Gain ($ Billion), Segmentation By Indication, 2025 – 2030

List Of Figures

Figure 1: Global Neurology Clinical Trials Market, Overview Of Key Products - Product Examples

Figure 2: Global Neurology Clinical Trials Market Attractiveness, Factor-Wise Evaluation

Figure 3: Global Neurology Clinical Trials Market, Supply Chain Analysis

Figure 4: Global Neurology Clinical Trials Market, Major Raw Material Providers

Figure 5: Global Neurology Clinical Trials Market, Major Resource Providers

Figure 6: Global Neurology Clinical Trials Market, Major Manufacturers (Suppliers)

Figure 7: Global Neurology Clinical Trials Market, Major Distributors And Channel Partners

Figure 8: Global Neurology Clinical Trials Market, Key Technologies & Future Trends

Figure 9: Global Neurology Clinical Trials Market, Major Trends

Figure 10: Global Neurology Clinical Trials Market, Major End Users

Figure 11: Global Neurology Clinical Trials Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis

Figure 12: Global Neurology Clinical Trials Historic Market Growth, 2020-2025, $ Billion

Figure 13: Global Neurology Clinical Trials Forecast Market Growth, 2025-2030F, 2035F, $ Billion

Figure 14: Global Neurology Clinical Trials Market - TAM, US$ Billion, 2025

Figure 15: Global Neurology Clinical Trials Market, Segmentation By Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 16: Global Neurology Clinical Trials Market, Segmentation By Study Design, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 17: Global Neurology Clinical Trials Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 18: Global Neurology Clinical Trials Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 19: Global Neurology Clinical Trials Market, Sub-Segmentation Of Phase I, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 20: Global Neurology Clinical Trials Market, Sub-Segmentation Of Phase II, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 21: Global Neurology Clinical Trials Market, Sub-Segmentation Of Phase III, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 22: Global Neurology Clinical Trials Market, Sub-Segmentation Of Phase IV, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 23: Global Neurology Clinical Trials Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 24: Global Neurology Clinical Trials Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 25: Asia-Pacific, Neurology Clinical Trials Market, Segmentation By Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 26: Asia-Pacific, Neurology Clinical Trials Market, Segmentation By Study Design, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 27: Asia-Pacific, Neurology Clinical Trials Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 28: China, Neurology Clinical Trials Market, Segmentation By Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 29: China, Neurology Clinical Trials Market, Segmentation By Study Design, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 30: China, Neurology Clinical Trials Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 31: India, Neurology Clinical Trials Market, Segmentation By Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 32: India, Neurology Clinical Trials Market, Segmentation By Study Design, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 33: India, Neurology Clinical Trials Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 34: Japan, Neurology Clinical Trials Market, Segmentation By Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 35: Japan, Neurology Clinical Trials Market, Segmentation By Study Design, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 36: Japan, Neurology Clinical Trials Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 37: Australia, Neurology Clinical Trials Market, Segmentation By Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 38: Australia, Neurology Clinical Trials Market, Segmentation By Study Design, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 39: Australia, Neurology Clinical Trials Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 40: Indonesia, Neurology Clinical Trials Market, Segmentation By Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 41: Indonesia, Neurology Clinical Trials Market, Segmentation By Study Design, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 42: Indonesia, Neurology Clinical Trials Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 43: South Korea, Neurology Clinical Trials Market, Segmentation By Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 44: South Korea, Neurology Clinical Trials Market, Segmentation By Study Design, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 45: South Korea, Neurology Clinical Trials Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 46: Taiwan, Neurology Clinical Trials Market, Segmentation By Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 47: Taiwan, Neurology Clinical Trials Market, Segmentation By Study Design, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 48: Taiwan, Neurology Clinical Trials Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 49: South East Asia, Neurology Clinical Trials Market, Segmentation By Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 50: South East Asia, Neurology Clinical Trials Market, Segmentation By Study Design, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 51: South East Asia, Neurology Clinical Trials Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 52: Western Europe, Neurology Clinical Trials Market, Segmentation By Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 53: Western Europe, Neurology Clinical Trials Market, Segmentation By Study Design, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 54: Western Europe, Neurology Clinical Trials Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 55: UK, Neurology Clinical Trials Market, Segmentation By Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 56: UK, Neurology Clinical Trials Market, Segmentation By Study Design, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 57: UK, Neurology Clinical Trials Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 58: Germany, Neurology Clinical Trials Market, Segmentation By Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 59: Germany, Neurology Clinical Trials Market, Segmentation By Study Design, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 60: Germany, Neurology Clinical Trials Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 61: France, Neurology Clinical Trials Market, Segmentation By Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 62: France, Neurology Clinical Trials Market, Segmentation By Study Design, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 63: France, Neurology Clinical Trials Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 64: Italy, Neurology Clinical Trials Market, Segmentation By Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 65: Italy, Neurology Clinical Trials Market, Segmentation By Study Design, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 66: Italy, Neurology Clinical Trials Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 67: Spain, Neurology Clinical Trials Market, Segmentation By Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 68: Spain, Neurology Clinical Trials Market, Segmentation By Study Design, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 69: Spain, Neurology Clinical Trials Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 70: Eastern Europe, Neurology Clinical Trials Market, Segmentation By Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 71: Eastern Europe, Neurology Clinical Trials Market, Segmentation By Study Design, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 72: Eastern Europe, Neurology Clinical Trials Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 73: Russia, Neurology Clinical Trials Market, Segmentation By Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 74: Russia, Neurology Clinical Trials Market, Segmentation By Study Design, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 75: Russia, Neurology Clinical Trials Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 76: North America, Neurology Clinical Trials Market, Segmentation By Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 77: North America, Neurology Clinical Trials Market, Segmentation By Study Design, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 78: North America, Neurology Clinical Trials Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 79: USA, Neurology Clinical Trials Market, Segmentation By Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 80: USA, Neurology Clinical Trials Market, Segmentation By Study Design, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 81: USA, Neurology Clinical Trials Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 82: Canada, Neurology Clinical Trials Market, Segmentation By Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 83: Canada, Neurology Clinical Trials Market, Segmentation By Study Design, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 84: Canada, Neurology Clinical Trials Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 85: South America, Neurology Clinical Trials Market, Segmentation By Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 86: South America, Neurology Clinical Trials Market, Segmentation By Study Design, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 87: South America, Neurology Clinical Trials Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 88: Brazil, Neurology Clinical Trials Market, Segmentation By Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 89: Brazil, Neurology Clinical Trials Market, Segmentation By Study Design, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 90: Brazil, Neurology Clinical Trials Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 91: Middle East, Neurology Clinical Trials Market, Segmentation By Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 92: Middle East, Neurology Clinical Trials Market, Segmentation By Study Design, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 93: Middle East, Neurology Clinical Trials Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 94: Africa, Neurology Clinical Trials Market, Segmentation By Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 95: Africa, Neurology Clinical Trials Market, Segmentation By Study Design, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 96: Africa, Neurology Clinical Trials Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 97: Global Neurology Clinical Trials Key Competitor Estimated Market Shares, 2024, Percentage (%)

Figure 98: Global Neurology Clinical Trials Market - Company Scoring Matrix

Figure 99: AbbVie Inc. Financial Performance

Figure 100: Sanofi S.A. Financial Performance

Figure 101: Novartis AG Financial Performance

Figure 102: Eli Lilly and Company Financial Performance

Figure 103: Teva Pharmaceutical Industries Ltd. Financial Performance

Figure 104: Global Neurology Clinical Trials Market, Competitive Benchmarking (In USD Billions)

Figure 105: Global Neurology Clinical Trials Market, Competitive Dashboard

Figure 106: Global Neurology Clinical Trials Market Size Gain ($ Billion), 2025 – 2030 By Country

Figure 107: Global, Neurology Clinical Trials Market Size Gain ($ Billion), Segmentation By Phase, 2025 – 2030

Figure 108: Global, Neurology Clinical Trials Market Size Gain ($ Billion), Segmentation By Study Design, 2025 – 2030

Figure 109: Global, Neurology Clinical Trials Market Size Gain ($ Billion), Segmentation By Indication, 2025 – 2030

Global Acute Care Telemedicine Market Forecast to Reach $66.59 Billion by 2029, Driven by 17.7% CAGR

2025–2029 Assistive Technology For Low Vision Market Outlook: Regional Trends and Growth Forecast

Global Biotechnology And Pharmaceutical Services Outsourcing Market Forecast to Reach $94.91 Billion by 2029, Driven by 7.2% CAGR

Cancer Treatment Facilities Market Revenue Outlook: Strategic Insights and Forecast to 2029

CAGR of 10.4% Projected for Catastrophic Antiphospholipid Syndrome Market From 2025 to 2029

Latest Market Developments in Clinical Risk Grouping Solution Industry: Forecast 2025–2029

2025–2029 Clinical Trial Investigative Site Network Market Outlook: Regional Trends and Growth Forecast

Future Demand and Leading Companies Shaping the Common Cold Market to 2029

Virtual Clinical Trials Market Report 2026 - Global Outlook – By Design (Observational Trials, Interventional Trials, Expanded Access Trials), By Phases (Phase II, Phase III, Phase IV), By Indication (CNS, Autoimmune Or ...

Clinical Trial Management Systems Market Report 2026 - Global Outlook – By Product (Enterprise-Based, Site-Based), By Components (Software, Services), By Delivery Mode (Web-based Clinical Trial Management Systems, On-Pre...

Interventional Oncology Devices Market Report 2026 - Global Outlook – By Product (Embolization Devices, Ablation Devices, Support Devices), By procedure (Thermal Tumor Ablation, Non-Thermal Tumor Ablation, Transcatheter ...

Clinical Trial Management System Market Report 2026 - Global Outlook – By System Type (Enterprise Based Clinical Trial Management System, Site Based Clinical Trial Management System), By Component (Software, Services, Ha...

Neurology Monitoring Market Report 2026 - Global Outlook – By Product Type (Magnetic Resonance Imaging (MRI) Devices, Electroencephalography Devices, Cerebral Oximeters, Intracranial Pressure Monitors, Other Product Type...

Clinical Trial Imaging Market Report 2026 - Global Outlook – By Product And Services (Services, Software), By Modality (Computed Tomography, Magnetic Resonance Imaging, Echocardiography, Nuclear Medicine, Positron Emissi...

Nephrologists Global Market Report 2020 - By Practice (Owner- Solo Practice, Owner- Group Practice, Full-time Employed, Partner), By Density (Higher Density Of Nephrologists, Median Density Of Nephrologists, Lower Densit...

Frequently Asked Questions

How big is the Neurology Clinical Trials Market?

The Neurology Clinical Trials market was valued at $5.8 billion in 2025, increased to $6.21 billion in 2026, and is projected to reach $8.05 billion by 2030.

What is the Neurology Clinical Trials market growth?

The global Neurology Clinical Trials market is expected to grow at a CAGR of 6.7% from 2026 to 2035 to reach $8.05 billion by 2035.

Who are the key players in Neurology Clinical Trials market?

Some Key Players in the Neurology Clinical Trials market Include, AbbVie Inc., Sanofi S.A., Novartis AG, Eli Lilly and Company, Teva Pharmaceutical Industries Ltd., IQVIA Holdings Inc., Biogen Inc., ICON plc., Syneos Health, Charles River Laboratories International Inc., Parexel International Corporation, CMIC Holdings Co. Ltd., Medpace Holdings Inc., PSI CRO AG., Supernus Pharmaceuticals Inc., Worldwide Clinical Trials LLC., Ergomed plc., Biotrial S.A.S., Clinilabs Drug Development Corporation, Lindus Health Ltd. .

What is the anticipated growth trend for the Neurology Clinical Trials market?

Major trend in this market includes: Innovative Therapies Using Monoclonal Antibodies Drive Progress In Neurological Disorder Treatment. For further insights on this market. request a sample here

Which region has the most growth potential in the Neurology Clinical Trials market?

North America was the largest region in the neurology clinical trials market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the neurology clinical trials market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.